Literature DB >> 26074707

Hepatitis B virus genotypes and genome characteristics in China.

Hong-Mei Li1, Jian-Qiong Wang1, Rui Wang1, Qian Zhao1, Li Li1, Jin-Ping Zhang1, Tao Shen1.   

Abstract

AIM: To analyze the hepatitis B virus (HBV) characters in China, as well as the correlation between several HBV mutation and hepatitis symptoms.
METHODS: A total of 1148 HBV genome sequences from patients throughout China were collected via the National Center For Biotechnology Information database (information including: genotype, territory and clinical status). HBV genotypes were classified by a direct reference from the Genbank sequence annotation, phylogenetic tree and online software analysis (http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi). The phylogenetic tree was constructed based on the neighbor-joining method by MEGA5.0 software. HBV sequences were grouped based on phylogenetic tree and the distance between the groups was calculated by using the computer between group mean distance methods. Seven hundred and twelve HBV sequences with clear annotation of clinical symptoms were selected to analyses the correlation of mutation and clinical symptoms. Characteristics of sequences were analyzed by using DNAStar and BioEdit software packages. The codon usage bias and RNA secondary structures analysis were performed by RNAdraw software. Recombination analysis was performed by using Simplot software.
RESULTS: In China, HBV genotype C was the predominant in Northeastern, genotype B was predominant in Central Southern areas, genotype B and C were both dominant in Southwestern areas, and the recombinant genotype C/D was predominant in Northwestern areas. C2 and B2 were identified as the two major sub-genotypes, FJ386674 might be a putative sub-genotype as B10. The basal core promoter double mutation and pre-C mutation showed various significant differences between hepatitis symptoms. In addition to ATG, many other HBV initiation codons also exist. HBV has codon usage bias; the termination codon of X, C and P open reading frames (ORF) were TAA, TAG, and TGA, respectively. The major stop codons of S-ORF were TAA (96.45%) and TGA (83.60%) in B2 and C2 subtype, respectively.
CONCLUSION: This study recapitulated the epidemiology of HBV in China, and the information might be meaningful critical for the future prevention and therapy of HBV infections.

Entities:  

Keywords:  Clinical symptoms; Codon usage bias; Genotype; Hepatitis B virus; Mutation; Phylogenetic tree

Mesh:

Substances:

Year:  2015        PMID: 26074707      PMCID: PMC4458779          DOI: 10.3748/wjg.v21.i21.6684

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  71 in total

1.  Under construction: classification of hepatitis B virus genotypes and subgenotypes.

Authors:  Stephan Schaefer; Lars Magnius; Helene Norder
Journal:  Intervirology       Date:  2009-09-29       Impact factor: 1.763

2.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

3.  Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam.

Authors:  Cuong Hung Nguyen; Azumi Ishizaki; Phan Thi Thu Chung; Huyen Thi Hoang; Trung Vu Nguyen; Tomoaki Tanimoto; Raphael Lihana; Kaori Matsushita; Xiuqiong Bi; Thuc Van Pham; Hiroshi Ichimura
Journal:  J Med Virol       Date:  2011-03       Impact factor: 2.327

4.  Hepatitis B virus with a proposed genotype I was found in Sichuan Province, China.

Authors:  Wenbin Tong; Jilan He; Li Sun; Shusen He; Qi Qi
Journal:  J Med Virol       Date:  2012-06       Impact factor: 2.327

Review 5.  Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan.

Authors:  Jia-Horng Kao
Journal:  Intervirology       Date:  2003       Impact factor: 1.763

6.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Authors:  Patricia Arauz-Ruiz; Helene Norder; Betty H Robertson; Lars O Magnius
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

7.  A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.

Authors:  Kanako Tatematsu; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Shuhei Mano; Tatsuji Maeshiro; Tomokuni Nakayoshi; Moriaki Wakuta; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

8.  Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan.

Authors:  Fuminaka Sugauchi; Hiromitsu Kumada; Hiroshi Sakugawa; Masafumi Komatsu; Hirofumi Niitsuma; Hisayoshi Watanabe; Yoshihiro Akahane; Hajime Tokita; Takanobu Kato; Yasuhito Tanaka; Etsuro Orito; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  Clin Infect Dis       Date:  2004-04-09       Impact factor: 9.079

9.  Detection of HBV genotypes of tumor tissues and serum by a fluorescence polarization assay in north-western China's hepatocellular carcinoma patients.

Authors:  Jianguo Lu; Weidong Gong; Hong Cheng; Zhiqun Wu; Ding Li; Xiangling Wang; Ping Liang; Ju Zhang
Journal:  Virol J       Date:  2011-07-22       Impact factor: 4.099

10.  A stem-loop structure directs oskar mRNA to microtubule minus ends.

Authors:  Helena Jambor; Sandra Mueller; Simon L Bullock; Anne Ephrussi
Journal:  RNA       Date:  2014-02-26       Impact factor: 4.942

View more
  14 in total

1.  Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).

Authors:  Hong-Yu Zhang; Long-Gen Liu; Chun-Yan Ye; Chun-Hua Chen; Shuang-Xiong Hang; Zhen Zhu; Hong-Yu Shen; Ze-Yu Huang; Wen-Yi Chen; Yuan Xue
Journal:  Virus Genes       Date:  2017-11-08       Impact factor: 2.332

2.  Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.

Authors:  Ming-Hui Li; Yao Xie; Lu Zhang; Yao Lu; Ge Shen; Shu-Ling Wu; Min Chang; Cai-Qin Mu; Lei-Ping Hu; Wen-Hao Hua; Shu-Jing Song; Shu-Feng Zhang; Jun Cheng; Dao-Zhen Xu
Journal:  World J Hepatol       Date:  2016-05-28

Review 3.  Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia.

Authors:  Qiuju Tian; Jidong Jia
Journal:  Hepatol Int       Date:  2016-06-14       Impact factor: 6.047

Review 4.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

5.  Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.

Authors:  Xiao-Ling Wang; Jian-Ping Ren; Xue-Qing Wang; Xiao-Hong Wang; Shao-Fang Yang; Yi Xiong
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

6.  Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China.

Authors:  Tianyi Ren; Huan Wang; Ruihong Wu; Junqi Niu
Journal:  Gastroenterol Res Pract       Date:  2017-07-31       Impact factor: 2.260

7.  Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.

Authors:  Xianlin Ye; Tong Li; Ran Li; Heng Liu; Junpeng Zhao; Jinfeng Zeng
Journal:  BMC Infect Dis       Date:  2021-01-19       Impact factor: 3.090

8.  The characteristic of the synonymous codon usage and phylogenetic analysis of hepatitis B virus.

Authors:  Xiaoming Qi; Chaojun Wei; Yonghong Li; Yu Wu; Hui Xu; Rui Guo; Yanjuan Jia; Zhenhao Li; Zhenhong Wei; Wanxia Wang; Jing Jia; Yuanting Li; Anqi Wang; Xiaoling Gao
Journal:  Genes Genomics       Date:  2020-05-27       Impact factor: 1.839

9.  Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.

Authors:  Mao-Bing Chen; Hua Wang; Qi-Han Zheng; Xu-Wen Zheng; Jin-Nuo Fan; Yun-Long Ding; Jia-Li Niu
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

10.  Case Report: Post-CAR-T Infusion HBV Reactivation in Two Lymphoma Patients Despite Entecavir Preventive Therapy.

Authors:  Yaxian Ma; Li Yang; Yuhan Bao; Yang Yang; Liting Chen; Miao Zheng
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.